Seegene KRX:096530KOSDAQ

씨젠 · Korean news coverage and regulatory filings, organized.

Articles, 24h0
Articles, 7 days1
DART filings, 7 days0
Articles tracked1since Sep 11

In Q2 2026, Seegene reported revenue of ₩136bn, up 19.2% year on year, and operating profit of ₩21.6bn. Seegene (씨젠) appeared in 1 Korean news article and 0 DART filings over the past seven days. Coverage peaked on Sep 14 with 1 article.

Seegene quarterly results consolidated, KRW

QuarterRevenueYoYOperating profitNet income
Q2 2026₩136bn+19.2%₩21.6bn₩26.0bn
Q1 2026₩129bn+11.3%₩23.6bn₩34.7bn
Q4 2025 derived₩131bn+13.3%₩6.9bn₩5.0bn
Q3 2025₩114bn+4.3%₩9.6bn₩14.6bn
Q2 2025₩114bn+13.9%₩3.1bn−₩71m
Q1 2025₩116bn+29.0%₩14.8bn₩28.9bn
Q4 2024 derived₩115bn+14.8%−₩6.2bn−₩44.1bn
Q3 2024₩109bn+18.4%₩5.3bn₩1.7bn

Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases.

Seegene top stories 2 weeks, by number of outlets

  1. 1
    진단 질환 다변화·수출 확대…씨젠·에스디바이오 실적 기지개
    1 outlets · 1 articlesFirst report Sep 14 07:00 서울경제

Latest Seegene news Korean headlines